Finally, the results indicated that the in vivo anti-tumor efficacy of the phage delivery system was mediated by the induction of tumor protection in BALB/c mice vaccinated with gpD::GP2 nanoparticles. This evidence concerns the gene ACKR1 and neoplasm.